130 related articles for article (PubMed ID: 19417749)
1. Biomarkers in gastroenterology: between hope and hype comes histopathology.
Jankowski JA; Odze RD
Am J Gastroenterol; 2009 May; 104(5):1093-6. PubMed ID: 19417749
[TBL] [Abstract][Full Text] [Related]
2. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
[TBL] [Abstract][Full Text] [Related]
4. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
5. [Genome analyses for precancerous lesions in the gastrointestinal tract].
Sowa M; Nakata B
Gan To Kagaku Ryoho; 2000 Mar; 27(3):335-40. PubMed ID: 10740625
[TBL] [Abstract][Full Text] [Related]
6. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation.
Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
J Pathol; 2006 Jan; 208(1):100-7. PubMed ID: 16278815
[TBL] [Abstract][Full Text] [Related]
7. How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.
Dundar M; Caglayan AO; Saatci C; Karaca H; Baskol M; Tahiri S; Ozkul Y
Cancer Genet Cytogenet; 2007 Sep; 177(2):95-7. PubMed ID: 17854661
[TBL] [Abstract][Full Text] [Related]
8. Molecular and cellular biology of pre-malignancy in the gastrointestinal tract.
Jass JR; Talbot IC
Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):175-89. PubMed ID: 11355910
[TBL] [Abstract][Full Text] [Related]
9. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
10. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus: can biomarkers predict progression to malignancy?
Tischoff I; Tannapfel A
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):653-63. PubMed ID: 19072343
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE).
Cronin J; McAdam E; Danikas A; Tselepis C; Griffiths P; Baxter J; Thomas L; Manson J; Jenkins G
Am J Gastroenterol; 2011 Jan; 106(1):46-56. PubMed ID: 21157443
[TBL] [Abstract][Full Text] [Related]
13. [Risk estimation in Barrett's esophagus: biomolecular marker and histopathologic classification].
Walch A; Schmitt-Gräff A; Stein H; Werner M
Zentralbl Chir; 2002 Dec; 127(12):1073-7. PubMed ID: 12529823
[TBL] [Abstract][Full Text] [Related]
14. Gastroesophageal reflux and cancer.
Turcotte S; Duranceau A
Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
[TBL] [Abstract][Full Text] [Related]
15. [New approaches to early detection, estimation of prognosis and therapy for malignant tumours of the gastrointestinal tract].
Röcken C; Neumann U; Ebert MP
Z Gastroenterol; 2008 Feb; 46(2):216-22. PubMed ID: 18253902
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and recognition of early esophageal neoplasia.
Herszényi L; Pregun I; Tulassay Z
Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
[TBL] [Abstract][Full Text] [Related]
17. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.
Esteller M; Sparks A; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Gonzalez S; Tarafa G; Sidransky D; Meltzer SJ; Baylin SB; Herman JG
Cancer Res; 2000 Aug; 60(16):4366-71. PubMed ID: 10969779
[TBL] [Abstract][Full Text] [Related]
18. The molecular biology of esophageal adenocarcinoma.
Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
Izzo JG; Wu TT; Wu X; Ensor J; Luthra R; Pan J; Correa A; Swisher SG; Chao CK; Hittelman WN; Ajani JA
J Clin Oncol; 2007 Feb; 25(6):698-707. PubMed ID: 17308274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
